Coeptis Therapeutics Hldgs I
13F holders, Q3 2025 (September 30)1holders −1
1new positions
0sold out
$17.46avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Coeptis Therapeutics Hldgs I in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 0 sold out. The largest holder was Anchor Investment Management, LLC ($122K).
- Company
- Coeptis Therapeutics Hldgs I
- CUSIP
- 19207A108
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $122K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q3 2025: 7,000 shares bought, net +7,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Anchor Investment Management, LLC | 0.01% | New | 7,000 | $122K |
"% of holder's portfolio" is COEPTIS THERAPEUTICS HLDGS I's weight in each manager's 13F, not the share of Coeptis Therapeutics Hldgs I the manager owns.